Document is current
Any future updates will be listed below
-
Authors
Cancellieri, Samuele https://orcid.org/0000-0003-2537-6728
Zeng, Jing
Lin, Linda Yingqi https://orcid.org/0000-0001-5011-1305
Tognon, Manuel https://orcid.org/0000-0002-6707-2071
Nguyen, My Anh
Lin, Jiecong
Bombieri, Nicola
Maitland, Stacy A.
Ciuculescu, Marioara-Felicia
Katta, Varun
Tsai, Shengdar Q. https://orcid.org/0000-0001-9161-3993
Armant, Myriam https://orcid.org/0000-0002-5205-3003
Wolfe, Scot A. https://orcid.org/0000-0002-7042-201X
Giugno, Rosalba https://orcid.org/0000-0001-9843-7638
Bauer, Daniel E. https://orcid.org/0000-0001-5076-7945
Pinello, Luca https://orcid.org/0000-0003-1109-3823
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (P01HL053749, OT2HL154984)
Doris Duke Charitable Foundation
St. Jude Children’s Research Hospital
Burroughs Wellcome Fund
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1HG009490, R35HG010717)
- License Information
-
More Information
Article History
Received: 4 July 2022
Accepted: 1 November 2022
First Online: 15 December 2022
Competing interests
: L.P. has financial interests in Edilytics, Excelsior Genomics and SeQure Dx. L.P.’s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. The remaining authors declare no competing interests.
